A tobacco reconceptualization in psychiatry: toward the development of tobacco-free psychiatric facilities.

The American Journal on Addictions
Taryn G MossTony P George

Abstract

Tobacco dependence is the leading cause of death in persons with psychiatric and substance use disorders. This has lead to interest in the development of pharmacological and behavioral treatments for tobacco dependence in this subset of smokers. However, there has been little attention paid to the development of tobacco-free environments in psychiatric institutions despite the creation of smoke-free psychiatric hospitals mandated by the Joint Commission for Accreditation of Health Organizations (JCAHO) in 1992. This review article addresses the reasons why tobacco should be excluded from psychiatric and addictions treatment settings, and strategies that can be employed to initiate and maintain tobacco-free psychiatric settings. Finally, questions for further research in this field are delineated. This Tobacco Reconceptualization in Psychiatry is long overdue, given the clear and compelling benefits of tobacco-free environments in psychiatric institutions.

References

Sep 1, 1992·The American Journal of Psychiatry·D C GoffE Amico
Feb 1, 1992·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·B F Hoffman, G Eryavec
Sep 1, 1991·The American Journal of Psychiatry·D Blumberg, M Safran
Nov 1, 1991·British Journal of Addiction·S T Tiffany, D J Drobes
Apr 1, 1991·Hospital & Community Psychiatry·M Greeman, T A McClellan
Dec 1, 1990·Hospital & Community Psychiatry·T A Bronaugh, R J Frances
Jan 1, 1989·Psychopharmacology·W A Corrigall, K M Coen
May 1, 1989·Hospital & Community Psychiatry·W R Smith, B L Grant
Jan 1, 1989·General Hospital Psychiatry·S R Thorward, S Birnbaum
Mar 1, 1986·Archives of General Psychiatry·J R Hughes, D Hatsukami
Jul 1, 1995·Psychiatric Services : a Journal of the American Psychiatric Association·P S Appelbaum
Mar 1, 1994·Hospital & Community Psychiatry·D M ZiedonisR J Frances
May 1, 1994·General Hospital Psychiatry·B M RyabikR Mount
Sep 1, 1993·Hospital & Community Psychiatry·J J Parks, D D Devine
Jan 1, 1993·General Hospital Psychiatry·N E TaylorP Friedman
Apr 10, 1996·JAMA : the Journal of the American Medical Association·R D HurtL J Melton
Aug 1, 1996·Psychiatric Services : a Journal of the American Psychiatric Association·J VelascoS Lippmann
Nov 7, 1998·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·J Addington, N el-Guebaly
Nov 13, 1998·The American Journal of Psychiatry·G W DalackJ H Meador-Woodruff
Jul 14, 1999·Psychiatric Services : a Journal of the American Psychiatric Association·J P LePage
Oct 3, 1999·Psychiatric Services : a Journal of the American Psychiatric Association·E R Lyon
Oct 27, 1999·The Journal of Nervous and Mental Disease·A J SwansonK R Cohen
Oct 21, 2000·The British Journal of Psychiatry : the Journal of Mental Science·S BrownB Barraclough
Nov 15, 2000·Administration and Policy in Mental Health·J QuinnP Fadow
Nov 22, 2000·JAMA : the Journal of the American Medical Association·K LasserD H Bor
Jun 29, 2001·Archives of General Psychiatry·D LichtermannJ Lönnqvist
Aug 17, 2001·The American Journal of Drug and Alcohol Abuse·D A D'MelloC C Colenda
Nov 6, 2001·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·A E EvinsD C Goff
Feb 1, 2002·Social Science & Medicine·Sharon J LawnJames G Barber
May 1, 2002·International Clinical Psychopharmacology·D F ZullinoP Baumann
Jun 25, 2002·Biological Psychiatry·Tony P GeorgeThomas R Kosten
Sep 20, 2002·Behavioral Sciences & the Law·Anthony G HempelAdele E Leinbach
Dec 4, 2002·Psychiatric Services : a Journal of the American Psychiatric Association·Nady El-GuebalySusan Gloster
May 15, 2003·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Sarah H HeilStephen T Higgins
Jul 23, 2003·Journal of Psychopharmacology·Catherine Greenwood-SmithDavid J Castle
Sep 12, 2003·Trends in Pharmacological Sciences·Marina R Picciotto
Nov 26, 2003·The American Journal of Psychiatry·Seth Himelhoch, Gail Daumit
Jan 16, 2004·Trends in Pharmacological Sciences·Tony P George, Stephanie S O'Malley
Mar 11, 2004·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·David KalmanPeter M Monti
Aug 4, 2004·Clinical Pharmacology and Therapeutics·Mirko S Faber, Uwe Fuhr

❮ Previous
Next ❯

Citations

Jul 24, 2012·Current Psychiatry Reports·Kristen M MackowickTony P George
Apr 23, 2013·Psychiatry Research·Wakako Umene-NakanoJun Nakamura
Sep 13, 2013·International Journal of Environmental Research and Public Health·Sharon Lawn, Jonathan Campion
Sep 12, 2015·The American Journal on Addictions·Marya MorozovaTony P George
Oct 17, 2012·International Journal of Mental Health Nursing·Rebecca Leigh MissenGiles Newton-Howes
Dec 2, 2011·Annals of the New York Academy of Sciences·Victoria C WingTony P George
Dec 30, 2014·Community Mental Health Journal·Daniel BergéAntoni Bulbena
Mar 1, 2017·Australian and New Zealand Journal of Public Health·Marguerite Thomas, Robyn Richmond
Apr 12, 2017·Journal of the American Psychiatric Nurses Association·Chizimuzo T C OkoliHeather Robertson
Mar 7, 2017·Journal of Psychiatric and Mental Health Nursing·M Thomas, R Richmond
Sep 14, 2014·Qualitative Health Research·Lyle G GrantJoan L Bottorff
Feb 19, 2016·Epidemiology and Psychiatric Sciences·M DochertyF Gaughran
Dec 5, 2019·European Heart Journal·Carolyn S P LamAdriaan A Voors

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.